Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 82

1.

Eryptosis Is Altered in Peritoneal Dialysis Patients.

Virzì GM, Milan Manani S, Clementi A, Castegnaro S, Brocca A, Riello C, de Cal M, Giuliani A, Battaglia GG, Crepaldi C, Ronco C.

Blood Purif. 2019 Jul 10:1-7. doi: 10.1159/000501541. [Epub ahead of print]

PMID:
31291616
2.

Neurohormonal, Endocrine, and Immune Dysregulation and Inflammation in Cardiorenal Syndrome.

Clementi A, Virzì GM, Battaglia GG, Ronco C.

Cardiorenal Med. 2019 Jul 2:1-9. doi: 10.1159/000500715. [Epub ahead of print] Review.

3.

Multi-Omics Approach: New Potential Key Mechanisms Implicated in Cardiorenal Syndromes.

Virzì GM, Clementi A, Battaglia GG, Ronco C.

Cardiorenal Med. 2019;9(4):201-211. doi: 10.1159/000497748. Epub 2019 Apr 2. Review.

4.

Multi-Biomarkers Panel in Cardiac Surgery Patients.

Clementi A, Virzì GM, Battaglia GG, Ronco C.

Blood Purif. 2019 Feb 6:1. doi: 10.1159/000497230. [Epub ahead of print] No abstract available.

5.

Presepsin and Procalcitonin Levels as Markers of Adverse Postoperative Complications and Mortality in Cardiac Surgery Patients.

Clementi A, Virzì GM, Muciño-Bermejo MJ, Nalesso F, Giavarina D, Carta M, Brocca A, de Cal M, Hinna Danesi T, Zanella M, Marchionna N, Brendolan A, Battaglia GG, Salvador L, Ronco C.

Blood Purif. 2019;47(1-3):140-148. doi: 10.1159/000494207. Epub 2018 Oct 18.

PMID:
30336490
6.

Ultrasound and color Doppler applications in chronic kidney disease.

Petrucci I, Clementi A, Sessa C, Torrisi I, Meola M.

J Nephrol. 2018 Dec;31(6):863-879. doi: 10.1007/s40620-018-0531-1. Epub 2018 Sep 6. Review.

PMID:
30191413
7.

Endotoxin Effects on Cardiac and Renal Functions and Cardiorenal Syndromes.

Virzì GM, Clementi A, Brocca A, Ronco C.

Blood Purif. 2017;44(4):314-326. doi: 10.1159/000480424. Epub 2017 Nov 22. Review.

8.

The Role of Endotoxin in the Setting of Cardiorenal Syndrome Type 5.

Clementi A, Virzì GM, Brocca A, Ronco C.

Cardiorenal Med. 2017 Oct;7(4):276-283. doi: 10.1159/000475846. Epub 2017 Jun 24. Review.

9.

Development and Characterization of a Parallelizable Perfusion Bioreactor for 3D Cell Culture.

Egger D, Fischer M, Clementi A, Ribitsch V, Hansmann J, Kasper C.

Bioengineering (Basel). 2017 May 25;4(2). pii: E51. doi: 10.3390/bioengineering4020051.

10.

Epigenetics: a potential key mechanism involved in the pathogenesis of cardiorenal syndromes.

Virzì GM, Clementi A, Brocca A, de Cal M, Ronco C.

J Nephrol. 2018 Jun;31(3):333-341. doi: 10.1007/s40620-017-0425-7. Epub 2017 Aug 5. Review.

PMID:
28780716
11.

Hemolytic Uremic Syndrome and Kidney Transplantation: A Case Series and Review of the Literature.

Milan Manani S, Virzì GM, Giuliani A, Clementi A, Brocca A, Dissegna D, Martino F, d''Amore ESG, Ronco C.

Nephron. 2017;136(3):245-253. doi: 10.1159/000468528. Epub 2017 Apr 19. Review.

PMID:
28419995
12.

A Single-Center Long-Term Continuous Subcutaneous Insulin Infusion (CSII) Experience: Higher Fractional Use Is Associated With Less Diabetes Complications.

Tubili C, Folco UD, Nardone MR, Clementi A.

J Diabetes Sci Technol. 2017 Sep;11(5):1057-1058. doi: 10.1177/1932296817702170. Epub 2017 Apr 3. No abstract available.

13.

Procalcitonin and Interleukin-6 Levels: Are They Useful Biomarkers in Cardiac Surgery Patients?

Clementi A, Brocca A, Virzì GM, de Cal M, Giavarina D, Carta M, Muciño-Bermejo MJ, Hinna Danesi T, Salvador L, Ronco C.

Blood Purif. 2017;43(4):290-297. doi: 10.1159/000454672. Epub 2017 Jan 25.

PMID:
28125806
14.

Cardiorenal Syndrome Type 5 in Sepsis: Role of Endotoxin in Cell Death Pathways and Inflammation.

Virzì GM, Clementi A, Brocca A, de Cal M, Marcante S, Ronco C.

Kidney Blood Press Res. 2016;41(6):1008-1015. doi: 10.1159/000452602. Epub 2016 Dec 23.

15.

Molecular and Genetic Mechanisms Involved in the Pathogenesis of Cardiorenal Cross Talk.

Virzì GM, Clementi A, Brocca A, de Cal M, Ronco C.

Pathobiology. 2016;83(4):201-10. doi: 10.1159/000444502. Epub 2016 Apr 21. Review.

16.

Cardiorenal syndrome type 4: From chronic kidney disease to cardiovascular impairment.

Granata A, Clementi A, Virzì GM, Brocca A, de Cal M, Scarfia VR, Zanoli L, Ronco C, Corrao S, Malatino L.

Eur J Intern Med. 2016 May;30:1-6. doi: 10.1016/j.ejim.2016.02.019. Epub 2016 Mar 6. Review.

PMID:
26961461
17.

The Role of Cell-Free Plasma DNA in Critically Ill Patients with Sepsis.

Clementi A, Virzì GM, Brocca A, Pastori S, de Cal M, Marcante S, Granata A, Ronco C.

Blood Purif. 2016;41(1-3):34-40. doi: 10.1159/000440975. Epub 2015 Oct 20.

PMID:
26960212
18.

Cellular apoptosis in the cardiorenal axis.

Virzì GM, Clementi A, Ronco C.

Heart Fail Rev. 2016 Mar;21(2):177-89. doi: 10.1007/s10741-016-9534-y. Review.

PMID:
26852141
19.

Pro-inflammatory cytokines: a possible relationship with dialytic adequacy and serum albumin in peritoneal dialysis patients.

Milan Manani S, Virzì GM, Clementi A, Brocca A, de Cal M, Tantillo I, Ferrando L, Crepaldi C, Ronco C.

Clin Kidney J. 2016 Feb;9(1):153-7. doi: 10.1093/ckj/sfv137. Epub 2015 Dec 13.

20.

Cardiorenal syndrome type 1: a defective regulation of monocyte apoptosis induced by proinflammatory and proapoptotic factors.

Pastori S, Virzì GM, Brocca A, de Cal M, Clementi A, Vescovo G, Ronco C.

Cardiorenal Med. 2015 Apr;5(2):105-15. doi: 10.1159/000371898. Epub 2015 Feb 11.

21.

Oxidative stress: dual pathway induction in cardiorenal syndrome type 1 pathogenesis.

Virzì GM, Clementi A, de Cal M, Brocca A, Day S, Pastori S, Bolin C, Vescovo G, Ronco C.

Oxid Med Cell Longev. 2015;2015:391790. doi: 10.1155/2015/391790. Epub 2015 Mar 4.

22.

Advances in the pathogenesis of cardiorenal syndrome type 3.

Clementi A, Virzì GM, Brocca A, de Cal M, Pastori S, Clementi M, Granata A, Vescovo G, Ronco C.

Oxid Med Cell Longev. 2015;2015:148082. doi: 10.1155/2015/148082. Epub 2015 Mar 4. Review.

23.

The hemodynamic and nonhemodynamic crosstalk in cardiorenal syndrome type 1.

Virzì GM, Clementi A, Brocca A, de Cal M, Vescovo G, Granata A, Ronco C.

Cardiorenal Med. 2014 Aug;4(2):103-12. doi: 10.1159/000362650. Epub 2014 May 14. Review.

24.

Cardiorenal syndrome type 4: management.

Clementi A, Virzì GM, Brocca A, de Cal M, Vescovo G, Granata A, Ronco C.

Blood Purif. 2013;36(3-4):200-9. doi: 10.1159/000356369. Epub 2013 Dec 20. Review.

25.

Effects of fluid overload on heart rate variability in chronic kidney disease patients on hemodialysis.

Ferrario M, Moissl U, Garzotto F, Cruz DN, Clementi A, Brendolan A, Tetta C, Gatti E, Signorini MG, Cerutti S, Ronco C.

BMC Nephrol. 2014 Feb 4;15:26. doi: 10.1186/1471-2369-15-26.

26.

An unusual case of posterior nutcracker syndrome.

Granata A, Clementi A, Floccari F, Di Lullo L, Basile A.

Clin Exp Nephrol. 2014 Aug;18(4):670-1. doi: 10.1007/s10157-014-0932-y. Epub 2014 Jan 31. No abstract available.

PMID:
24481951
27.

Secondary amyloidosis in a patient carrying mutations in the familial Mediterranean fever (FMF) and tumour necrosis factor receptor-1 syndrome (TRAPS) genes.

Clementi A, Cruz DN, Granata A, Virzì GM, Battaglia G.

Clin Kidney J. 2013 Dec;6(6):613-617. Epub 2013 Sep 24.

28.

Cardiorenal syndrome type 4: a review.

Clementi A, Virzì GM, Goh CY, Cruz DN, Granata A, Vescovo G, Ronco C.

Cardiorenal Med. 2013 Apr;3(1):63-70. doi: 10.1159/000350397.

29.

Rapidly progressive glomerulonephritis in a patient with familial Mediterranean fever and renal amyloidosis.

Granata A, Clementi A, Scarfia RV, Insalaco M, Fatuzzo P.

Ren Fail. 2013 Oct;35(9):1304. doi: 10.3109/0886022X.2013.824382. Epub 2013 Aug 7. No abstract available.

PMID:
23924034
30.

Rhabdomyolysis and acute kidney injury secondary to interaction between simvastatin and cyclosporine.

Scarfia RV, Clementi A, Granata A.

Ren Fail. 2013 Aug;35(7):1056-7. doi: 10.3109/0886022X.2013.810540. No abstract available.

PMID:
23859539
31.

[Effects of dose of erythropoiesis stimulating agents on cardiovascular outcomes, quality of life and costs of haemodialysis. the clinical evaluation of the DOSe of erythropoietins (C.E. DOSE) Trial].

Saglimbene V, D'Alonzo D, Ruospo M, Vecchio M, Natale P, Gargano L, Nicolucci A, Pellegrini F, Craig JC, Triolo G, Procaccini DA, Santoro A, Di Giulio S, La Rosa S, Murgo A, Di Toro Mammarella R, Sambati M, D'Ambrosio N, Greco V, Giannoccaro G, Flammini A, Boccia E, Montalto G, Pagano S, Amarù S, Fici M, Lumaga GB, Mancini E, Veronesi M, Patregnani L, Querques M, Schiavone P, Chimienti S, Palumbo R, Di Franco D, Della Volpe M, Gori E, Salomone M, Iacono A, Moscoloni M, Treglia A, Casu D, Piras AM, Di Silva A, Mandreoli M, Lopez A, Quarello F, Catizone L, Russo G, Forcellini S, Maccarone M, Catucci G, Di Paolo B, Stingone A, D'Angelo B, Guastoni C, Pasquali S, Minoretti C, Bellasi A, Boscutti G, Martone M, David S, Schito F, Urban L, Di Iorio B, Caruso F, Mazzoni A, Musacchio R, Andreoli D, Cossu M, Li Cavoli G, Cornacchiari M, Granata A, Clementi A, Giordano R, Guastoni C, Barzaghi W, Valentini M, Hegbrant J, Tognoni G, Strippoli GF.

G Ital Nefrol. 2013 Mar-Apr;30(2). pii: gin/30.2.21. Italian.

PMID:
23832463
32.

Contrast-enhanced ultrasound reveals renal artery aneurysm after detection of 'parapelvic lithiasis'.

Granata A, Floccari F, Clementi A, Di Lullo L, Fiorini F.

Clin Exp Nephrol. 2014 Feb;18(1):174-5. doi: 10.1007/s10157-013-0829-1. Epub 2013 Jun 26. No abstract available.

PMID:
23801377
33.

Evaluation of the efficacy of a cognitive rehabilitation treatment on a group of Alzheimer's patients with moderate cognitive impairment: a pilot study.

Salotti P, De Sanctis B, Clementi A, Fernandez Ferreira M, De Silvestris T.

Aging Clin Exp Res. 2013 Aug;25(4):403-9. doi: 10.1007/s40520-013-0062-5. Epub 2013 Jun 13.

PMID:
23760946
34.

[Parenchymal complications of the transplanted kidney: the role of color-Doppler imaging].

Granata A, Clementi S, Clementi A, Di Pietro F, Scarfia VR, Insalaco M, Aucella F, Prencipe M, Fiorini F, Sicurezza E.

G Ital Nefrol. 2012 Nov-Dec;29 Suppl 57:S90-8. Italian.

PMID:
23229534
35.

[Ultrasound assessment in renal infections].

Granata A, Floccari F, Insalaco M, Clementi A, Di Lullo L, D'Amelio A, Zamboli P, Logias F, Romano M, Fiorini F.

G Ital Nefrol. 2012 Nov-Dec;29 Suppl 57:S47-57. Italian.

PMID:
23229529
36.

Genomics and biological activity of neutrophil gelatinase-associated lipocalin in several clinical settings.

Virzì GM, Clementi A, de Cal M, Cruz DN, Ronco C.

Blood Purif. 2013;35(1-3):139-43. doi: 10.1159/000346100. Epub 2013 Jan 22. Review.

37.

Carotid intima-media thickness and liver histology in hemodialysis patients with nonalcoholic Fatty liver disease.

Neri S, Signorelli SS, Scuderi R, Bruno M, Bertino G, Clementi A, Torrisi I, Fidone F, Pagano AB, Malaguarnera M, Noto R.

Int J Angiol. 2011 Sep;20(3):149-56. doi: 10.1055/s-0031-1283218.

38.

Statin therapy is associated with decreased small, dense low-density lipoprotein levels in patients undergoing peritoneal dialysis.

Clementi A, Kim JC, Floris M, Cruz DN, Garzotto F, Zanella M, Nalesso F, Brendolan A, Giavarina D, Soffiati G, Ronco C.

Contrib Nephrol. 2012;178:111-115. doi: 10.1159/000337829. Epub 2012 May 25.

PMID:
22652726
39.

Computational modeling of effects of mechanical shaking on hemodynamics in hollow fibers.

Kim JC, Garzotto F, Cruz DN, Clementi A, Nalesso F, Kim JH, Kang E, Kim HC, Ronco C.

Int J Artif Organs. 2012 Apr 30;35(4):301-7. doi: 10.5301/ijao.5000094. Epub 2012 Apr 13.

PMID:
22505197
40.

Sepsis and AKI in ICU Patients: The Role of Plasma Biomarkers.

Lentini P, de Cal M, Clementi A, D'Angelo A, Ronco C.

Crit Care Res Pract. 2012;2012:856401. doi: 10.1155/2012/856401. Epub 2012 Feb 14.

41.

Role of biomarkers in the diagnosis and management of cardio-renal syndromes.

Cruz DN, Fard A, Clementi A, Ronco C, Maisel A.

Semin Nephrol. 2012 Jan;32(1):79-92. doi: 10.1016/j.semnephrol.2011.11.011. Review.

PMID:
22365166
42.

Evaluation of a new polysulfone hemofilter for continuous renal replacement therapy.

Floris M, Marchionna N, Clementi A, Kim JC, Cruz DN, Nalesso F, Zanella M, Garzotto F, de Cal M, Virzì GM, Brendolan A, Ronco C.

Blood Purif. 2011;32(2):133-8. doi: 10.1159/000325221. Epub 2011 Jun 7.

PMID:
21654165
43.

Deletion of interleukin-6 improves pyruvate tolerance without altering hepatic insulin signaling in the leptin receptor-deficient mouse.

Clementi AH, Gaudy AM, Zimmers TA, Koniaris LG, Mooney RA.

Metabolism. 2011 Nov;60(11):1610-9. doi: 10.1016/j.metabol.2011.04.004. Epub 2011 May 31.

44.

Body composition and heart rate variability to achieve dry weight and tolerance.

Nalesso F, Ferrario M, Moissl U, Brendolan A, Zanella M, Cruz DN, Basso F, Floris M, Clementi A, Garzotto F, Tetta C, Signorini MG, Cerrutti S, Ronco C.

Contrib Nephrol. 2011;171:181-186. doi: 10.1159/000327334. Epub 2011 May 23. Review.

PMID:
21625109
45.

Antioxidant dialytic approach with vitamin E-coated membranes.

Panagiotou A, Nalesso F, Zanella M, Brendolan A, de Cal M, Cruz D, Basso F, Floris M, Clementi A, Ronco C.

Contrib Nephrol. 2011;171:101-106. doi: 10.1159/000327204. Epub 2011 May 23. Review.

PMID:
21625097
46.

Renal involvement in leishmaniasis: a review of the literature.

Clementi A, Battaglia G, Floris M, Castellino P, Ronco C, Cruz DN.

NDT Plus. 2011 Jun;4(3):147-52. doi: 10.1093/ndtplus/sfr008. Epub 2011 Mar 21. Review.

47.

Suppressor of cytokine signaling-3 is a glucagon-inducible inhibitor of PKA activity and gluconeogenic gene expression in hepatocytes.

Gaudy AM, Clementi AH, Campbell JS, Smrcka AV, Mooney RA.

J Biol Chem. 2010 Dec 31;285(53):41356-65. doi: 10.1074/jbc.M110.159111. Epub 2010 Oct 26.

48.

Loss of Kupffer cells in diet-induced obesity is associated with increased hepatic steatosis, STAT3 signaling, and further decreases in insulin signaling.

Clementi AH, Gaudy AM, van Rooijen N, Pierce RH, Mooney RA.

Biochim Biophys Acta. 2009 Nov;1792(11):1062-72. doi: 10.1016/j.bbadis.2009.08.007. Epub 2009 Aug 20.

49.

Cisplatin-induced kidney injury in the rat: L-carnitine modulates the relationship between MMP-9 and TIMP-3.

Martinez G, Costantino G, Clementi A, Puglia M, Clementi S, Cantarella G, De Meo L, Matera M.

Exp Toxicol Pathol. 2009 May;61(3):183-8. doi: 10.1016/j.etp.2008.07.004. Epub 2008 Nov 6.

PMID:
18993041
50.

Luminance and chromatic visual evoked potentials in type I and type II diabetes: relationships with peripheral neuropathy.

Gregori B, Galié E, Pro S, Clementi A, Accornero N.

Neurol Sci. 2006 Nov;27(5):323-7.

PMID:
17122941

Supplemental Content

Loading ...
Support Center